Patent US5145776A successfully refreshed from Google Patents.
US5145776A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of using T7 DNA polymerase to mutagenize and fill-in DNA
Assignee: Harvard University
•
Filing: 1990-03-07
•
Granted: 1992-09-08
•
Expires: 2010-03-07
Abstract
Abstract Methods for producing blunt-ended double stranded DNA, for labelling the 3'-end of a DNA fragment, and for in vitro mutagenesis of a DNA fragment. A processive DNA polymerase is used in each method.
Inventors
- 👤 Stanley Tabor
- 👤 Charles C. Richardson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 10:26
CPC Classifications
C; C12; C12P; C12P19/00; C12P19/26; C12P19/28; C12P19/30; C12P19/34; C12N; C12N9/00; C12N9/10; C12N9/12; C12N9/1241; C12N9/1252
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
99 words
A method for in vitro mutagenesis of a cloned DNA fragment comprising providing said cloned fragment and a T7-type DNA polymerase, contacting said cloned fragment with said polymerase under conditions suitable for synthesizing a DNA strand from said fragment, wherein said T7-type DNA polymerase has less than 500 units of exonuclease activity per mg of polymerase and is produced from recombinant DNA, and wherein said conditions cause formation of said DNA strand by incorporation of a plurality of individual contiguous bases able to base-pair with said fragment and incorporation of a nucleotide base unable to base-pair with said fragment.
Claim 2
Independent Claim
99 words
A method for in vitro mutagenesis of a cloned DNA fragment comprising providing said cloned fragment and a T7-type DNA polymerase, contacting said cloned fragment with said polymerase under conditions suitable for synthesizing a DNA strand from said fragment, wherein said T7-type DNA polymerase has less than 500 units of exonuclease activity per mg of polymerase and is produced from recombinant DNA, and wherein said conditions cause formation of said DNA strand by incorporation of a plurality of individual contiguous bases able to base-pair with said fragment and incorporation of a nucleotide base unable to base-pair with said fragment.
Claim 3
Independent Claim
70 words
A method for in vitro mutagenesis of a template DNA fragment comprising providing a primer and said template, said primer having contiguous bases able to base-pair with contiguous bases of said template except at least one base which is unable to base-pair with said template, and extending said primer with a T7-type DNA polymerase having less than 500 units of exonuclease activity per mg of polymerase produced from recombinant DNA.
Claim 4
Independent Claim
70 words
A method for in vitro mutagenesis of a template DNA fragment comprising providing a primer and said template, said primer having contiguous bases able to base-pair with contiguous bases of said template except at least one base which is unable to base-pair with said template, and extending said primer with a T7-type DNA polymerase having less than 500 units of exonuclease activity per mg of polymerase produced from recombinant DNA.
Claim 5
Dependent Claim
14 words
The method of claim 2, wherein said T7-type DNA polymerase is T7 DNA polymerase.
Claim 6
Independent Claim
99 words
A method for in vitro mutagenesis of a cloned DNA fragment comprising providing said cloned fragment and a T7-type DNA polymerase, contacting said cloned fragment with said polymerase under conditions suitable for synthesizing a DNA strand from said fragment, wherein said T7-type DNA polymerase has less than 500 units of exonuclease activity per mg of polymerase and is produced from recombinant DNA, and wherein said conditions cause formation of said DNA strand by incorporation of a plurality of individual contiguous bases able to base-pair with said fragment and incorporation of a nucleotide base unable to base-pair with said fragment.
Claim 7
Independent Claim
99 words
A method for in vitro mutagenesis of a cloned DNA fragment comprising providing said cloned fragment and a T7-type DNA polymerase, contacting said cloned fragment with said polymerase under conditions suitable for synthesizing a DNA strand from said fragment, wherein said T7-type DNA polymerase has less than 500 units of exonuclease activity per mg of polymerase and is produced from recombinant DNA, and wherein said conditions cause formation of said DNA strand by incorporation of a plurality of individual contiguous bases able to base-pair with said fragment and incorporation of a nucleotide base unable to base-pair with said fragment.
Claim 8
Dependent Claim
14 words
The method of claim 4, wherein said T7-type DNA polymerase is T7 DNA polymerase.
Claim 9
Independent Claim
82 words
A method for producing blunt-ended double stranded DNA from a linear DNA molecule having a 5' end comprising a single stranded region, wherein the 3' end of said molecule is double stranded and has no 3' protruding termini, comprising incubating said DNA molecule with a T7-type DNA polymerase having a reduced exonuclease activity compared to naturally occurring exonuclease activity; wherein said polymerase is produced from recombinant DNA and acts on said single stranded region to produce a blunt-ended double stranded DNA molecule.
Claim 10
Independent Claim
82 words
A method for producing blunt-ended double stranded DNA from a linear DNA molecule having a 5' end comprising a single stranded region, wherein the 3' end of said molecule is double stranded and has no 3' protruding termini, comprising incubating said DNA molecule with a T7-type DNA polymerase having a reduced exonuclease activity compared to naturally occurring exonuclease activity; wherein said polymerase is produced from recombinant DNA and acts on said single stranded region to produce a blunt-ended double stranded DNA molecule.
Claim 11
Dependent Claim
14 words
The method of claim 6, wherein said T7-type DNA polymerase is T7 DNA polymerase.
Claim 12
Independent Claim
66 words
A method for labelling the 3' end of a DNA fragment comprising a 5' single-stranded region, wherein the 3' end of said molecule is double stranded and has no 3' protruding termini, said method comprising incubating said DNA fragment with a T7-type DNA polymerase having less than 500 units of exonuclease activity per mg of polymerase, which is produced from recombinant DNA, and a labelled deoxynucleotide.
Claim 13
Independent Claim
66 words
A method for labelling the 3' end of a DNA fragment comprising a 5' single-stranded region, wherein the 3' end of said molecule is double stranded and has no 3' protruding termini, said method comprising incubating said DNA fragment with a T7-type DNA polymerase having less than 500 units of exonuclease activity per mg of polymerase, which is produced from recombinant DNA, and a labelled deoxynucleotide.
Claim 14
Dependent Claim
14 words
The method of claim 8, wherein said T7-type DNA polymerase is T7 DNA polymerase.
References Cited (Backward Citations)
US3444042A
Cited
US3444041A
Cited
US3661893A
Cited
US4072574A
Cited
US4363877A
Cited
US4363877B1
Cited
US4224408A
Cited
US4331589A
Cited
US4591565A
Cited
US4663283A
Cited
US4555486A
Cited
US4394443A
Cited
US4395486A
Cited
US4563419A
Cited
US4486539A
Cited
US4663290A
Cited
US4483922A
Cited
US4483920A
Cited
US4556643A
Cited
US4521509A
Cited
US4656127A
Cited
US4683196A
Cited
US4729947A
Cited
US4786600A
Cited
US4675283A
Cited
US4767708A
Cited
US4670379A
Cited
US4795700A
Cited
US4683202A
Cited
US4683202B1
Cited
US4707235A
Cited
US4800159A
Cited
EP0258017A2
Cited
US4795699A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-09-08 | 1996-03-09 | 1996-09-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-09-08 | 2000-03-09 | 2000-09-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-09-08 | 2004-03-09 | 2004-09-08 | $7700.00 | Window Closed / Lapsed |